Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists

British Journal of Cancer

Volumn 83, Issue 7, 2000, Pages 906-913

  Chatzistamou, I ^a,b   Schally, A V ^a,b   Sun, B ^a,b   Armatis, P ^a   Szepeshazi, K ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin GRP antagonists; C fos; C jun; Cancer therapy; LH RH antagonist; Ovarian tumours

Indexed keywords

BOMBESIN ANTAGONIST; BOMBESIN RECEPTOR; CETRORELIX; GASTRIN RELEASING PEPTIDE; GONADORELIN ANTAGONIST; GROWTH FACTOR; MESSENGER RNA; RC 3095; RC 3940II; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LATENT PERIOD; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

EID: 0033834522     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1374     Document Type: Article

References (45)

1. New antagonists of LH-RH: II. Inhibition and potentiation of LH-RH by closely related analogues
2. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity
3. Bombesin stimulates growth of human prostatic cancer cells in vitro
4. 2 or its derivatives
5. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptides
6. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GNRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro
7. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
8. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells
9. Effects of LH-RH-analogues on mitogenic signal transduction in cancer cells
10. C-jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities
11. Characterization of bombesin/GRP receptors in human breast cancer and their relationship to steroid receptor expression
12. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095
13. A new human ovarian carcinoma celt line: Establishment and analysis of tumour associated markers
14. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
15. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
16. Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II
17. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide
18. Novel expression and regulation of gastrin gene in human ovarian cancer cell line, SW626
19. Bombesin/Gastrin-Releasing Peptide Antagonists RC-3095 and RC-3940-II inhibit tumour growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma
20. Cancer Statistics, 1999
21. Cancer mortality in Europe and an overview of trends from 1955-1994
22. Synergistic effects of bombesin and epidermal growth factor on cancers
23. Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation
24. Inhibition of growth of MDA-MB-231 human breast Cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095
25. Growth factor and peptide receptors in small cell lung cancer
26. Cloning of a receptor for amphibian [PheI3]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BR4)
27. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro
28. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors
29. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi
30. 2
31. Hypothalamic and other peptide hormones
32. Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF7-MIII human breast cancer xenografts in nude mice
33. Production of gastrin-releasin peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions
34. Bombesin-like peptides: Of ligands and receptors
35. The presence of receptors for bombesin/GRP and mRNA for throe receptor subtypes in human ovarian epithelial cancers
36. The presence of receptors for bombesin/gastrin-releasing peptide and mRNA for 3 receptor subtypes in human prostate cancers
37. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095
38. A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers
39. Determination of subcutaneous tumour size in athymic (nude) mice
40. UKCCCR (1998) United Kingdom Coordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (2nd edn)
41. Bombesin may stimulate proliferation of human pancreatic cancer cells througn an autocrine pathway
42. Stimulation by bombesin and inhibition by bombesin/gastrin releasing peptide antagonist RC-3950 of growth of human breast cancer cell lines
43. Inhibitory effect of bombesin/GRP antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice
44. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75